Skip to main content

Cancer imaging: principles and practice

  • Chapter

Abstract

Unlike the majority of imaging modalities used in the management of patients with suspected or proven malignancy, which rely on alterations in structure to visualize the tumour site, nuclear medicine imaging techniques utilize the ability to visualize alterations in metabolism. These alterations in metabolism may occur in the tissues surrounding the tumour site or may occur in the tumour itself. Radiopharmaceuticals used in tumour imaging may also be divided into those that are specifically taken up by tumours and those whose uptake is non-specific. These non-specific agents also localize in other pathological processes such as inflammation. In this chapter, the principles underlying the localization of radiopharmaceuticals used for tumour imaging will be discussed (Table 2.1) and the role of nuclear medicine in the management of cancer patients will be explored.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sirisrio, R., Podoloff, D.A., Patt, Y.Z. et al. (1996) Tc-99m-Immu4 imaging in recurrent colorectal cancer: efficacy and impact on surgical management. Nucl. Med. Commun., 17, 568–76.

    Article  Google Scholar 

  2. Krenning, E.P., Kwekkeboom, D.J., Bakker, W.H. et al. (1993) Somatostatin receptor scintigraphy with 111In-DTPA-D-Phe and 123I-Tyr3-octreotide: the Rotterdam Experience with more than 1000 patients. Eur. J. Nucl. Med., 20, 716–31.

    Article  PubMed  CAS  Google Scholar 

  3. Virgolini, I., Raderer, M., Kurtaran, A. et al. (1994) Vasoactive Intestinal Peptide receptor imaging for the localisation of intestinal adenocarcinomas and endocrine tumours. N. Engl. J. Med., 331, 1116–21.

    Article  PubMed  CAS  Google Scholar 

  4. Bomanji, J., Levison, D.A., Flatman, W.D. et al. (1987) Uptake of I-123 metaiodobenzylguanadine by pheochromocytomas, other paraganliomas and neuroblastomas: a histopathological comparison. J. Nucl. Med., 23, 973–8.

    Google Scholar 

  5. Gambhir, S.S., Hoh, C.K., Phelps, M.E., Madar, I. and Maddahi, J. (1996) Decision tree sensitivity analysis for cost effectiveness of FDG-PET in the staging and management of non small cell lung carcinoma. J. Nucl Med., 37, 1428–36.

    PubMed  CAS  Google Scholar 

  6. Strauss, L.G. (1996) Fluorine-18 deoxyglucose and false positive results: a major problem in the diagnostics of oncological patients. Eur. J. Nucl Med., 23, 1409–15.

    Article  PubMed  CAS  Google Scholar 

  7. Babaian, R.J., Sayer, J., Podoloff, D.A. et al. (1994) Radioimmunoscintigraphy of pelvic lymph nodes with 111In-labelled monoclonal antibody CYT-356. J. Urol, 152, 1952–5.

    PubMed  CAS  Google Scholar 

  8. Elmore, J.G., Wells, C.K., Lee, C.H. et al. (1994) Variability in radiologists’ interpretations of mammograms. N. Engl. J. Med., 331, 1493–9.

    Article  PubMed  CAS  Google Scholar 

  9. Khalkhali, I., Mena, I. and Diggles, L. (1994) A review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimam-mography using technetium-99m sestamibi. Eur. J. Nucl. Med., 21, 357–62.

    Article  PubMed  CAS  Google Scholar 

  10. Kao, C.K., Wang, S.J. and Liu, T.J. (1994) The use of technetium-99m methoxyisobutyl isonitrile breast scintigraphy to evaluate palpable breast masses. Eur. J. Nucl. Med., 21, 432–6.

    PubMed  CAS  Google Scholar 

  11. Palmedo, H., Schomberg, A., Grunwald, F. et al. (1995) Mammoscintigraphy with Tc-99m MIBI in patients with suspicious breast nodules: a comparison of planar and SPECT imaging techniques. Eur.J. Nucl Med., 22, 725.

    Google Scholar 

  12. Piccolo, S., Lastoria, S., Mainolfi, C. et al. (1995) Technetium-99m-Methylene diphosphonate scintimammography to image primary breast cancer. J. Nucl. Med., 36, 718–24.

    PubMed  CAS  Google Scholar 

  13. Wahl, R.L., Cody, R.L., Hutchins, G.D. and Mudgett, E.E. (1991) Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabelled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology, 179, 765–70.

    PubMed  CAS  Google Scholar 

  14. Fischer, B., Redmond, C. and Fischer, E.R. (1985) Ten year results of randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N. Engl. J. Med., 312, 674–81.

    Article  Google Scholar 

  15. Silverstein, M.J., Gierson, E.D., Waisman, J.R. et al. (1994) Axillary lymph node dissection for T1a breast carcinoma — Is it indicated? Cancer, 73, 664–7.

    Article  PubMed  CAS  Google Scholar 

  16. Avril, N., Janicke, F., Dose, J. et al. (1995) Evaluation of axillary lymph node involvement in breast cancer patients using F-18 FDG PET. Eur. J. Nucl. Med., 22, 733.

    Google Scholar 

  17. Epenetos, A.A., Britton, K.E., Mather, S. et al. (1982) Targetting of Iodine-123 labelled tumour-associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet, ii, 999–1005.

    Article  Google Scholar 

  18. McEwan, A.H.B., Akran, U., Boniface, C. et al. (1994) Tc-99m MAb 170 H.82 in the evaluation of locoregional disease in patients with breast cancer. Eur. J. Nucl Med., 21, S15.

    Google Scholar 

  19. Granowska, M., Biassoni, L., Carroll, M. et al. (1996) Breast cancer Tc-99m radioimmunoscintigraphy. Acta Oncologica, 35, 319–21.

    Article  PubMed  CAS  Google Scholar 

  20. Biassoni, L., Granowska, M., Carroll, M.J. et al. (1997) Tc-99m labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection. Br. J. Cancer. (in press).

    Google Scholar 

  21. Krag, D.N., Weaver, D.L., Alex, J.C. and Fairbank, J.T. (1993) Surgical resection and radiolocalisation of the sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol, 2, 335–40.

    Article  PubMed  CAS  Google Scholar 

  22. Paganelli, G., De Cicco, C., Cremonesi, M. et al. (1997) Gamma-probe guided resection of the sentinel node in breast cancer. J. Nucl Med., 38, 97P.

    Google Scholar 

  23. Veronesi, U., Paganelli, G., Galimberti, V. et al. (1997) Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet, 349, 1864–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Clarke, S.E.M., Britton, K.E. (1998). Cancer imaging: principles and practice. In: Maisey, M.N., Britton, K.E., Collier, B.D. (eds) Clinical Nuclear Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3356-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-3356-0_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-75180-6

  • Online ISBN: 978-1-4899-3356-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics